WHO recommends new vaccine for prevention of malaria in children

Betsy Goodfellow | October 3, 2023 | News story | Medical Communications Immunology, Vaccine, WHO, malaria, malaria vaccine 

The World Health Organization (WHO) has announced that it has recommended a new vaccine, R21/Matrix-M, for the prevention of malaria in children.

This recommendation follows advice from WHO’s Strategic Advisory Group of Experts on Immunization (SAGE) and the Malaria Policy Advisory Group (MPAG), as well as being endorsed by WHO’s director-general during its regular biannual meeting on 25-29 September 2023.

As well as the new malaria vaccine, WHO also issued recommendations on vaccines for dengue and meningitis, as well as immunisation schedules and product recommendations for COVID-19, following the advice of SAGE.

This malaria vaccine is the second to be recommended by WHO, following RTS,S/AS01 which was recommended in 2021. Both have demonstrated safety and efficacy in preventing malaria in children and are expected to have a large impact on public health.

Dr Tedros Adhanom Ghebreyesus, WHO’s director-general, commented: “As a malaria researcher, I used to dream of the day we would have a safe and effective vaccine against malaria. Now we have two. Demand for the RTS,S vaccine far exceeds supply, so this second vaccine is a vital additional tool to protect more children faster, and to bring us closer to our vision of a malaria-free future.”

Betsy Goodfellow

Related Content

GSK shares new data for RSV vaccine Arexvy

GSK announced positive results from its phase 3 trial which assessed the immune response and …

GSK and Zhifei partner for shingles vaccine promotion in China

GSK has announced that it has come to an exclusive agreement with Chingqing Zhifei Biological …


Vaxart shares topline data from phase 2 study of norovirus vaccine candidate

Vaxart has announced topline data from its phase 2 challenge study which assessed its oral …

Latest content